Novo Nordisk A/S

Novo Nordisk is a global pharmaceutical leader and the world's largest insulin producer, headquartered in Bagsværd near Copenhagen. With over 60,000 employees and a market capitalization that has made it Europe's most valuable company, Novo Nordisk is the crown jewel of Denmark's life sciences sector. The in-house legal department manages pharmaceutical regulation and Danish Medicines Agency (Lægemiddelstyrelsen) compliance, clinical trial agreements, intellectual property and patent portfolio management, competition law (including EU pharmaceutical sector investigations), GDPR/data protection for health data, and corporate governance under the Danish Companies Act (Selskabsloven). The legal team also handles complex global IP litigation protecting the company's GLP-1 receptor agonist portfolio.